Name Net increased
positions
Increased positions Reduced positions Return since
30 Sep ‘22
226
18 26 8 62.1%
227
18 114 96 71.6%
228
18 28 10 61.5%
XPEL icon
229
XPEL
XPEL
$1.27B
18 62 44 27.3%
230
18 67 49 42%
231
18 67 49 49.9%
232
18 59 41 5.46%
233
18 99 81 76.4%
234
18 65 47 6.06%
235
18 74 56 17.9%
AMLX icon
236
Amylyx Pharmaceuticals
AMLX
$1.94B
18 38 20 38.5%
237
18 74 56 54.3%
238
18 88 70 59.1%
239
18 28 10 77.7%
240
18 58 40 312%
241
18 40 22 205%
242
18 59 41 71.5%
243
17 56 39 19%
244
17 49 32 37.2%
245
17 70 53 6.68%
246
17 47 30 48.4%
247
17 36 19 57.4%
248
17 39 22 30%
249
17 49 32 20.6%
250
17 23 6 19.2%